ValuEngine upgraded shares of MedEquities Realty Trust (NYSE:MRT) from a hold rating to a buy rating in a research note issued to investors on Monday morning.
Several other research analysts also recently commented on the company. Cantor Fitzgerald reissued a buy rating and set a $14.00 target price on shares of MedEquities Realty Trust in a research note on Wednesday, February 21st. Zacks Investment Research downgraded MedEquities Realty Trust from a buy rating to a hold rating in a research note on Wednesday, January 3rd. B. Riley set a $13.00 target price on MedEquities Realty Trust and gave the stock a buy rating in a research note on Thursday, February 22nd. Finally, Citigroup lowered their target price on MedEquities Realty Trust from $12.00 to $10.00 and set a neutral rating for the company in a research note on Thursday, March 1st. Three equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. The stock currently has an average rating of Buy and a consensus price target of $12.50.
MedEquities Realty Trust stock opened at $10.40 on Monday. The company has a market capitalization of $329.71, a PE ratio of 16.25 and a beta of 0.21. MedEquities Realty Trust has a 52 week low of $9.67 and a 52 week high of $13.06.
MedEquities Realty Trust (NYSE:MRT) last issued its earnings results on Wednesday, February 21st. The financial services provider reported $0.18 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.31 by ($0.13). The business had revenue of $16.23 million for the quarter, compared to analyst estimates of $16.31 million. MedEquities Realty Trust had a return on equity of 5.99% and a net margin of 34.96%. The firm’s revenue was up 13.8% compared to the same quarter last year. During the same period in the previous year, the firm posted ($0.06) EPS. equities research analysts anticipate that MedEquities Realty Trust will post 1.21 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which was paid on Monday, March 5th. Stockholders of record on Monday, February 19th were issued a dividend of $0.21 per share. This represents a $0.84 annualized dividend and a dividend yield of 8.08%. The ex-dividend date was Thursday, February 15th. MedEquities Realty Trust’s dividend payout ratio (DPR) is currently 131.25%.
Several large investors have recently added to or reduced their stakes in the company. Parametric Portfolio Associates LLC grew its holdings in shares of MedEquities Realty Trust by 4.4% during the second quarter. Parametric Portfolio Associates LLC now owns 40,531 shares of the financial services provider’s stock worth $512,000 after purchasing an additional 1,704 shares during the last quarter. Sumitomo Mitsui Trust Holdings Inc. grew its holdings in shares of MedEquities Realty Trust by 29.7% during the third quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 26,829 shares of the financial services provider’s stock worth $315,000 after purchasing an additional 6,143 shares during the last quarter. The Manufacturers Life Insurance Company grew its holdings in shares of MedEquities Realty Trust by 42.5% during the second quarter. The Manufacturers Life Insurance Company now owns 26,586 shares of the financial services provider’s stock worth $335,000 after purchasing an additional 7,923 shares during the last quarter. LSV Asset Management bought a new stake in shares of MedEquities Realty Trust during the fourth quarter worth about $103,000. Finally, JPMorgan Chase & Co. bought a new stake in shares of MedEquities Realty Trust during the third quarter worth about $118,000. Institutional investors own 92.76% of the company’s stock.
TRADEMARK VIOLATION WARNING: This report was originally posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this report on another domain, it was illegally stolen and republished in violation of U.S. and international trademark & copyright legislation. The original version of this report can be accessed at https://www.dispatchtribunal.com/2018/03/20/medequities-realty-trust-mrt-raised-to-buy-at-valuengine.html.
About MedEquities Realty Trust
MedEquities Realty Trust, Inc is a real estate investment trust (REIT). The Company invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company invests primarily in real estate across the acute and post-acute spectrum of care. It focuses on investing in various types of healthcare properties, including acute care hospitals; skilled nursing facilities; short-stay surgical and specialty hospitals, which focus on orthopedic, heart and other dedicated surgeries and specialty procedures; dedicated specialty hospitals, such as inpatient rehabilitation facilities, long-term acute care hospitals and facilities providing psychiatric care; physician clinics; diagnostic facilities; outpatient surgery centers, and facilities that support these services, such as medical office buildings.
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for MedEquities Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.